Covestor’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-138
Closed -$1K – 2897
2026
Q2
$1K Buy
138
+118
+590% +$754 ﹤0.01% 2395
2026
Q1
$0 Sell
20
-155
-89% -$1.03K ﹤0.01% 2834
2025
Q4
$1K Sell
175
-146
-45% -$1.15K ﹤0.01% 2202
2025
Q3
$3K Buy
321
+28
+10% +$186 ﹤0.01% 1905
2025
Q2
$1K Sell
293
-86
-23% -$394 ﹤0.01% 2127
2025
Q1
$2K Buy
+379
New +$1.53K ﹤0.01% 1904

Other funds holding XERS

Covestor's XERS Position: Q3 2026 in Review

Covestor sold out of Xeris Biopharma Holdings (XERS) in Q3 2026, closing a stake of 138 shares — an estimated $1K sold.

Covestor first reported a position in XERS in Q1 2025 and held it in 6 quarters. The position peaked at $3K in Q3 2025. 249 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Covestor reported no remaining Xeris Biopharma Holdings position as of Q3 2026 after selling out during the quarter.
  • Covestor sold 138 Xeris Biopharma Holdings shares in Q3 2026, an estimated $1K.
  • Covestor first reported a position in Xeris Biopharma Holdings in Q1 2025 and held it in 6 quarters.
  • Covestor's Xeris Biopharma Holdings position peaked at $3K in Q3 2025.
  • 249 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.